Literature DB >> 8579947

Dose-response effects of estradiol implants on bone mineral density in ovariectomized ewes.

A S Turner1, C H Mallinckrodt, M R Alvis, H U Bryant.   

Abstract

In a longitudinal in vivo study, we studied the effect of two different doses of 17 beta-estradiol (E2) administered in the form of a subcutaneous implant, on bone mineral density (BMD) of the lumbar vertebrae (L4, L5, L4-L6/L5-L7), the calcaneus (CAL) and the distal radius (DR) in ovariectomized (OVX) ewes. The BMD of various regions of the femur, tibia and humerus were studied at autopsy. Skeletally mature ewes (n = 45) were divided into four groups: sham operated (n = 12), OVX (n = 15), OVX plus one E2 implant (OVXE, n = 12) and OVX plus two E2 implants (OVX2E, n = 6). BMD of L4, L5, L4-L6/L5-L7, CAL and DR was determined at 0, 6 and 12 months using dual-energy X-ray absorptiometry. In-vivo precision of BMD for the last three lumbar vertebrae ranged from 1.4-4.3%, and 1.5% and 3.5% for CAL and DR respectively. In the in vivo study, there were no significant changes in the mean BMD in the sham group at any time point (each group served as its own control). In the OVX group, mean BMD was significantly lower at L5 and DR at 6 months and significantly lower at L4 at 12 months. In the OVXE group, the mean BMD was significantly higher at L5, CAL and DR at 12 months. In the OVX2E group, BMD was significantly higher at CAL but significantly lower at L4 at 12 months. None of the treatments produced significant changes of mean BMD of L4-L6/L5-L7 at any time point.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8579947     DOI: 10.1016/8756-3282(95)00321-4

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  5 in total

1.  Is centrally induced alveolar bone loss in a large animal model preventable by peripheral hormone substitution?

Authors:  Maciej J K Simon; Frank Timo Beil; Pia Pogoda; Eik Vettorazzi; Iain Clarke; Michael Amling; Ralf Oheim
Journal:  Clin Oral Investig       Date:  2017-06-02       Impact factor: 3.573

2.  Mesoporous bioactive glass/ɛ-polycaprolactone scaffolds promote bone regeneration in osteoporotic sheep.

Authors:  N Gómez-Cerezo; L Casarrubios; M Saiz-Pardo; L Ortega; D de Pablo; I Díaz-Güemes; B Fernández-Tomé; S Enciso; F M Sánchez-Margallo; M T Portolés; D Arcos; M Vallet-Regí
Journal:  Acta Biomater       Date:  2019-04-06       Impact factor: 8.947

3.  Recovery Effects of a 180 mT Static Magnetic Field on Bone Mineral Density of Osteoporotic Lumbar Vertebrae in Ovariectomized Rats.

Authors:  Shenzhi Xu; Hideyuki Okano; Naohide Tomita; Yoshito Ikada
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-28       Impact factor: 2.629

4.  A Novel Peptide, CK2.3, Improved Bone Formation in Ovariectomized Sprague Dawley Rats.

Authors:  Linda Sequeira; John Nguyen; Liyun Wang; Anja Nohe
Journal:  Int J Mol Sci       Date:  2020-07-10       Impact factor: 5.923

Review 5.  Osteoporosis Preclinical Research: A Systematic Review on Comparative Studies Using Ovariectomized Sheep.

Authors:  Francesca Salamanna; Deyanira Contartese; Francesca Veronesi; Lucia Martini; Milena Fini
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.